Results
1 -
10 of
121Nathan R. Rose, Michael A. McDonough, Oliver N. F. King, Akane Kawamura and Christopher J. Schofield.
Inhibition of 2-oxoglutarate dependent oxygenases, Chem. Soc. Rev., 2011, 40, 4364. Nadine Martinet, Benoît Y. Michel, Philippe Bertrand and Rachid Benhida.
Small molecules DNA methyltransferases inhibitors, Med. Chem. Commun., 2012, 3, 263. Benjamin P. Burton-Pye, Sarah L. Heath and Stephen Faulkner.
Synthesis and luminescence properties of lanthanide complexes incorporating a hydralazine-derived chromophore, Dalton Trans., 2005, 0, 146. Lisa M. Kaminskas, Simon M. Pyke and Philip C. Burcham.
Reactivity of hydrazinophthalazine drugs with the lipid peroxidation products acrolein and crotonaldehyde, Org. Biomol. Chem., 2004, 2, 2578. Nicolas Audic, Guy Potier and N. André Sasaki.
New 2,3-diaminopropionic acid inhibitors of AGE and ALE formation, Org. Biomol. Chem., 2013, 11, 773. The effects of DNA methylation and histone deacetylase inhibitors on human papillomavirus early gene expression in cervical cancer, an in vitro and clinical study, Virology Journal Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines, Cancer Cell International Hemodynamic Effects of Combined Inotropic and Vasodilator Drugs in Severe Congestive Heart Failure: Hydralazine and Prenalterol, Vasodilators in Chronic Heart Failure Effects of nifedipine versus hydralazine on sympathetic activity and cardiac function in patients with hypertension persisting on diuretic plus beta-blocker therapy, Cardiovascular Drugs and Therapy